Scienture Holdings, Inc.
SCNXNASDAQHealthcare● Active
$0.35
$-0.01(-2.22%)
Market Cap$5425942
P/E Ratio—
52W High$2.6
52W Low$0.238
Scienture Holdings, Inc. (SCNX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SCNX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.08
Est. -$0.23 · +65.2%
Revenue
$0.00B
Est. $0.00B · -86.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
SCNX reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 17, 2026 | -$0.23 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 11, 2026 | -$0.23 | -$0.08 | +65.2% | $0.00B | $0.00B | -86.0% |
| ▼ Q1 FY2026 | Mar 24, 2026 | -$0.22 | -$1.76 | -700.0% | $-0.00B | $0.00B | -134.7% |
| — Q4 FY2025 | Nov 12, 2025 | — | -$0.19 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 12, 2025 | — | -$0.48 | — | — | — | — |
| — Q2 FY2025 | May 12, 2025 | — | -$0.33 | — | $0.00B | — | — |
| — Q1 FY2025 | Mar 26, 2025 | — | -$0.82 | — | $0.00B | $0.00B | -97.9% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.15 | -$1.34 | -793.3% | $0.00B | $0.00B | -97.4% |
Q3 FY2026
Aug 17, 2026
EPS Actual
—
EPS Est.
-$0.23
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Beat
EPS Actual
-$0.08
EPS Est.
-$0.23
EPS Surpr.
+65.2%
Revenue
$0.00B
Q1 FY2026
Mar 24, 2026Miss
EPS Actual
-$1.76
EPS Est.
-$0.22
EPS Surpr.
-700.0%
Revenue
$-0.00B
Q4 FY2025
Nov 12, 2025
EPS Actual
-$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 12, 2025
EPS Actual
-$0.48
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 12, 2025
EPS Actual
-$0.33
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 26, 2025
EPS Actual
-$0.82
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$1.34
EPS Est.
-$0.15
EPS Surpr.
-793.3%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Q3 FY2026 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q2 FY2026 | $-0.23 | $-0.23 | $-0.23 | 1 |
| Q1 FY2026 | $-0.22 | $-0.22 | $-0.22 | 1 |
| Q4 FY2025 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q3 FY2025 | $-0.15 | $-0.15 | $-0.15 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 11, 2026 | +65.2% | $0.40 | $0.40 | +0.95% |
| ▼ Q1 FY2026 | Mar 24, 2026 | -700.0% | $0.48 | $0.46 | -5.08% |
| — Q4 FY2025 | Nov 12, 2025 | — | $0.74 | $0.71 | -3.98% |
| — Q3 FY2025 | Aug 12, 2025 | — | $2.12 | $2.09 | -1.42% |
| — Q2 FY2025 | May 12, 2025 | — | $0.92 | $0.94 | +2.16% |
| — Q1 FY2025 | Mar 26, 2025 | — | $1.77 | $1.71 | -3.39% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -793.3% | $7.83 | $8.06 | +2.94% |
| ▼ Q3 FY2024 | Aug 9, 2024 | -593.3% | No price data | $7.49 | — |
Q2 FY2026+0.95%
Report Date
May 11, 2026
EPS Beat/Miss
+65.2%
Price Before
$0.40
Price After
$0.40
Q1 FY2026-5.08%
Report Date
Mar 24, 2026
EPS Beat/Miss
-700.0%
Price Before
$0.48
Price After
$0.46
Q4 FY2025-3.98%
Report Date
Nov 12, 2025
EPS Beat/Miss
—
Price Before
$0.74
Price After
$0.71
Q3 FY2025-1.42%
Report Date
Aug 12, 2025
EPS Beat/Miss
—
Price Before
$2.12
Price After
$2.09
Q2 FY2025+2.16%
Report Date
May 12, 2025
EPS Beat/Miss
—
Price Before
$0.92
Price After
$0.94
Q1 FY2025-3.39%
Report Date
Mar 26, 2025
EPS Beat/Miss
—
Price Before
$1.77
Price After
$1.71
Q4 FY2024+2.94%
Report Date
Nov 6, 2024
EPS Beat/Miss
-793.3%
Price Before
$7.83
Price After
$8.06
Q3 FY2024—
Report Date
Aug 9, 2024
EPS Beat/Miss
-593.3%
Price Before
—
Price After
$7.49
Avg Beat Reaction+0.95%
Avg Miss Reaction-1.07%
Beat Rate1 / 8 quarters
Largest Move-5.08% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SCNX ends December
Scienture Holdings, Inc. (SCNX) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.08 — beating the analyst consensus of $-0.23 by +65.2%. The next SCNX earnings date is expected around September 1, 2026.
Each quarter, investors track SCNX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SCNX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SCNX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SCNX earnings · 5 questionsScienture Holdings, Inc.'s next earnings report is expected around September 1, 2026. SCNX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SCNX historically reports after market close (AMC).
SCNX earnings datewhen is SCNX earningsSCNX next earnings datewhen does SCNX report earningsSCNX earnings calendar
▸ Source: FMP · Scienture Holdings, Inc. SEC filings · US GAAP · Scienture Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026